The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Changing epidemiology of hepatocellular carcinoma in Asia
Open accessAbstract
Liver cancer is the fifth most common cancer and the second leading cause of malignant death in Asia, and Asia reports 72.5% of the world's cases in 2020. As the most common histological type, hepatocellular carcinoma (HCC) accounts for the majority of incidence and mortality of liver cancer cases. This review presents the changing epidemiology of HCC in Asian countries in recent years. Globally, aged, male and Asian populations remain the group with the highest risk of HCC. Hepatitis B virus (HBV) and hepatitis C virus (HCV) are still the leading risk factors of HCC with a slight decline in most Asian countries, which is mainly attributed to HBV vaccination of newborns, prevention of HCV horizontal transmission and treatment of chronic hepatitis. However, the prevalence of HCC caused by metabolic factors, including metabolic syndrome, obesity and non‐alcoholic fatty liver diseases, is increasing rapidly in Asian countries, which may eventually become the major cause of HCC. Excessive alcohol consumption continues to be an important risk factor as the average consumption of alcohol is still growing. Hopefully, great effort has been made to better prevention and treatment of HCC in most Asian regions, which significantly prolongs the survival of HCC patients. Asian countries tend to use more aggressive intervention than European and American countries, but it remains unclear whether this preference is related to a better prognosis. In conclusion, HCC remains a major disease burden in Asia, and the management of HCC should be adjusted dynamically based on the changing epidemiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
Keum, N., & Giovannucci, E. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0189-8 · Cited by 2,661
Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & El‐Serag, H. B. (2021) · Hepatology · doi:10.1002/hep.31288 · Cited by 2,147
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
Bagnardi, V, Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V, Scotti, L., Jenab, M., Turati, F., Pasquali, E., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.579 · Cited by 1,342
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Gao, Q., Zhu, H., Dong, L., Shi, W., Chen, R., Song, Z., Huang, C., Li, J., Dong, X., Zhou, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.052 · Cited by 1,096
Self-citationHepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., D’Angelica, M. I., Abbott, D. E., Anaya, D. A., Anders, R., Are, C., Bachini, M., Borad, M., Brown, D., Burgoyne, A., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0022 · Cited by 1,003
Global Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study
Manthey, J., Shield, K. D., Rylett, M., Hasan, O. S. M., Probst, C., & Rehm, J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32744-2 · Cited by 856
Ranasinghe, P., Mathangasinghe, Y., Jayawardena, R., Hills, A. P., & Misra, A. (2017) · BMC Public Health · doi:10.1186/s12889-017-4041-1 · Cited by 746
Kudo, M., Kawamura, Y., Hasegawa, K., Tateishi, R., Kariyama, K., Shiina, S., Toyoda, H., Imai, Y., Hiraoka, A., Ikeda, M., et al. (2021) · Liver Cancer · doi:10.1159/000514174 · Cited by 678
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
Zhou, J., Yu, L., Gao, X., Hu, J., Wang, J., Dai, Z., Wang, J.-F., Zhang, Z., Lu, S., Huang, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2697 · Cited by 635
Self-citationSangiovanni, A., Del Ninno, E., Fasani, P., De Fazio, C., Ronchi, G., Romeo, R., Morabito, A., de Franchis, R., & Colombo, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.049 · Cited by 600
International trends in hepatocellular carcinoma incidence, 1978–2012
Petrick, J. L., Florio, A. A., Znaor, A., Ruggieri, D., Laversanne, M., Alvarez, C. S., Ferlay, J., Valery, P. C., Bray, F., & McGlynn, K. A. (2020) · International Journal of Cancer · doi:10.1002/ijc.32723 · Cited by 594
Buch, S., Stickel, F., Trépo, E., Way, M., Herrmann, A., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3417 · Cited by 565
Wong, V. W., Chan, W., Chitturi, S., Chawla, Y., Dan, Y. Y., Duseja, A., Fan, J., Goh, K., Hamaguchi, M., Hashimoto, E., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13857 · Cited by 506
Self-citationAnuurad, E., Shiwaku, K., Nogi, A., Kitajima, K., Enkhmaa, B., Shimono, K., & Yamane, Y. (2003) · Journal of Occupational Health · doi:10.1539/joh.45.335 · Cited by 414
The changing epidemiology of liver diseases in the Asia–Pacific region
Wong, M. C. S., Huang, J. L. W., George, J., Huang, J., Leung, C., Eslam, M., Chan, H. L. Y., & Ng, S. C. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0055-0 · Cited by 344
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030
Zheng, R., Office for Cancer Registry, N. C. C. C. R. C. F. C. H., Qu, C., Zhang, S., Zeng, H., Sun, K., Gu, X., Xia, C., Yang, Z., Li, H., et al. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.06.01 · Cited by 343
Self-citationNonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Ahmed, A., Wong, R. J., & Harrison, S. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.029 · Cited by 327
Pinyol, R., Montal, R., Bassaganyas, L., Sia, D., Takayama, T., Chau, G.-Y., Mazzaferro, V., Roayaie, S., Lee, H. C., Kokudo, N., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316408 · Cited by 326
Yin, J., Li, N., Han, Y., Xue, J., Deng, Y., Shi, J., Guo, W., Zhang, H., Wang, H., Cheng, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5896 · Cited by 307
Comparison of hepatocellular carcinoma in Eastern versus Western populations
Choo, S. P., Tan, W. L., Goh, B. K. P., Tai, W. M., & Zhu, A. X. (2016) · Cancer · doi:10.1002/cncr.30237 · Cited by 264
Golabi, P., Paik, J. M., AlQahtani, S., Younossi, Y., Tuncer, G., & Younossi, Z. M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.022 · Cited by 259
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
Chang, M.-H., You, S.-L., Chen, C.-J., Liu, C.-J., Lai, M.-W., Wu, T.-C., Wu, S.-F., Lee, C.-M., Yang, S.-S., Chu, H.-C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.048 · Cited by 258
Self-citationChen, L.-T., Martinelli, E., Cheng, A.-L., Pentheroudakis, G., Qin, S., Bhattacharyya, G. S., Ikeda, M., Lim, H.-Y., Ho, G. F., Choo, S. P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.12.001 · Cited by 234
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
Tateishi, R., Uchino, K., Fujiwara, N., Takehara, T., Okanoue, T., Seike, M., Yoshiji, H., Yatsuhashi, H., Shimizu, M., Torimura, T., et al. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-018-1532-5 · Cited by 231
ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective
Chang, J. S., Hsiao, J.-R., & Chen, C.-H. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0327-y · Cited by 223
Kisiel, J. B., Dukek, B. A., V.S.R. Kanipakam, R., Ghoz, H. M., Yab, T. C., Berger, C. K., Taylor, W. R., Foote, P. H., Giama, N. H., Onyirioha, K., et al. (2019) · Hepatology · doi:10.1002/hep.30244 · Cited by 210
The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma
Bonilla Guerrero, R., & Roberts, L. R. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.005 · Cited by 204
Lu, J., Zhang, X.-P., Zhong, B.-Y., Lau, W. Y., Madoff, D. C., Davidson, J. C., Qi, X., Cheng, S.-Q., & Teng, G.-J. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30178-5 · Cited by 204
Mycotoxin control in low- and middle-income countries
Amuzie, C. J., Bandyopadhyay, R., Bhat, R. V., Black, R. E., Burger, H. ‐., Cardwell, K. F., Gelderblom, W. C. A., Gong, Y. Y., Groopman, J. D., Kimanya, M. E., et al. (2016) · HAL · Cited by 197
Epidemiology of liver cancer in South Korea
Kim, B. H., & Park, J.-W. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0112 · Cited by 189
Caruso, S., Calatayud, A.-L., Pilet, J., La Bella, T., Rekik, S., Imbeaud, S., Letouzé, E., Meunier, L., Bayard, Q., Rohr-Udilova, N., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.001 · Cited by 186
Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis
Brar, G., Greten, T. F., Graubard, B. I., McNeel, T. S., Petrick, J. L., McGlynn, K. A., & Altekruse, S. F. (2020) · Hepatology Communications · doi:10.1002/hep4.1564 · Cited by 178
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis
Nahon, P., & Zucman-Rossi, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.035 · Cited by 176
Tobacco Smoking and Mortality in Asia: A Pooled Meta-analysis
Yang, J. J., Yu, D., Wen, W., Shu, X.-O., Saito, E., Rahman, S., Gupta, P. C., He, J., Tsugane, S., Xiang, Y.-B., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.1474 · Cited by 173
Qu, C., Wang, Y., Wang, P., Chen, K., Wang, M., Zeng, H., Lu, J., Song, Q., Diplas, B. H., Tan, D., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819799116 · Cited by 170
The Changing Epidemiology of Primary Liver Cancer
Petrick, J. L., & McGlynn, K. A. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-00188-3 · Cited by 170
Wu, E. M., Wong, L. L., Hernandez, B. Y., Ji, J., Jia, W. P., Kwee, S. A., & Kalathil, S. C. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.87 · Cited by 166
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors
Huang, M. N., Yu, W., Teoh, W. W., Ardin, M., Jusakul, A., Ng, A. W. T., Boot, A., Abedi‐Ardekani, B., Villar, S., Myint, S. S., et al. (2017) · Genome Research · doi:10.1101/gr.220038.116 · Cited by 165
Reduced Aflatoxin Exposure Presages Decline in Liver Cancer Mortality in an Endemic Region of China
Chen, J.-G., Egner, P. A., Ng, D., Jacobson, L. P., Muñoz, A., Zhu, Y.-R., Qian, G.-S., Wu, F., Yuan, J.-M., Groopman, J. D., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0168 · Cited by 164
Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma
Zhang, W., He, H., Zang, M., Wu, Q., Zhao, H., Lu, L.-L., Ma, P., Zheng, H., Wang, N., Zhang, Y., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.024 · Cited by 163
Fukuda, T., Hamaguchi, M., Kojima, T., Hashimoto, Y., Ohbora, A., Kato, T., Nakamura, N., & Fukui, M. (2015) · Liver International · doi:10.1111/liv.12912 · Cited by 162
Han, J., Xian, Z., Zhang, Y., Liu, J., & Liang, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00648 · Cited by 162
Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma
An, P., Xu, J., Yu, Y., & Winkler, C. A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00261 · Cited by 156
Jinjuvadia, R., Patel, S., & Liangpunsakul, S. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182a030c4 · Cited by 145
Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan
Kudo, M., Izumi, N., Sakamoto, M., Matsuyama, Y., Ichida, T., Nakashima, O., Matsui, O., Ku, Y., Kokudo, N., Makuuchi, M., et al. (2016) · Liver Cancer · doi:10.1159/000367775 · Cited by 143
Dash, S., Aydın, Y., Widmer, K., & Nayak, L. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s221187 · Cited by 141
Wp, K., Robien, K., Wang, R., Govindarajan, S., Yuan, J.-M., & Mc, Y. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.360 · Cited by 138
Lonardo, A., Ballestri, S., Guaraldi, G., Nascimbeni, F., Romagnoli, D., Zona, S., & Targher, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i44.9674 · Cited by 135
Li, B., Yan, C., Zhu, J., Chen, X., Fu, Q., Zhang, H., Tong, Z., Liu, L., Zheng, Y., Zhao, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01037 · Cited by 132
New frontiers in liver resection for hepatocellular carcinoma
Allaire, M., Goumard, C., Lim, C., Cleach, A. L., Wagner, M., & Scatton, O. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100134 · Cited by 132
Chang, T., Wu, Y.-C., Tung, S., Wei, K.-L., Hsieh, Y., Huang, H.-C., Chen, W., Shen, C.-H., Lu, C.-H., Wu, C., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.100 · Cited by 128
The changing scenario of hepatocellular carcinoma in Italy: an update
Garuti, F., Neri, A., Avanzato, F., Gramenzi, A., Rampoldi, D., Rucci, P., Farinati, F., Giannini, E. G., Piscaglia, F., Rapaccini, G. L., et al. (2020) · Liver International · doi:10.1111/liv.14735 · Cited by 124
Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms
Zheng, B. J., Zhu, Y., Wang, H., & Chen, L. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9043-9 · Cited by 122
Liver Fluke-Associated Biliary Tract Cancer
Prueksapanich, P., Piyachaturawat, P., Aumpansub, P., Ridtitid, W., Chaiteerakij, R., & Rerknimitr, R. (2018) · Gut and Liver · doi:10.5009/gnl17102 · Cited by 118
Zhang, L., Wang, G., Hou, W., et al. (2009) · Hepatology · doi:10.1002/hep.23384 · Cited by 109
Yi, S., Choi, J., Yi, J., Lee, Y., & Han, K. J. (2018) · Cancer · doi:10.1002/cncr.31406 · Cited by 103
Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity
Caruso, S., O’Brien, D. R., Cleary, S. P., Roberts, L. R., & Zucman‐Rossi, J. (2020) · Hepatology · doi:10.1002/hep.31394 · Cited by 103
Yan, H., Yang, Y., Zhang, L., Tang, G., Wang, Y.-Z., Xue, G., Zhou, W., & Sun, S.-H. (2015) · Hepatology · doi:10.1002/hep.27722 · Cited by 100
Lao, X., Luo, G., Ye, L., Luo, C., Shi, M., Wang, D., Guo, R., Chen, M., Li, S., Lin, X., et al. (2013) · Liver International · doi:10.1111/liv.12112 · Cited by 95
Epidemiology and prevention of hepatitis B virus infection in China
Lu, F., Li, T., Liu, S., & Zhuang, H. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01266.x · Cited by 93
Hassanipour, S., Vali, M., Gaffari-fam, S., Nikbakht, H., Abdzadeh, E., Joukar, F., Pourshams, A., Shafaghi, A., Malakoutikhah, M., Arab‐Zozani, M., et al. (2020) · EXCLI journal · doi:10.17179/excli2019-1842 · Cited by 83
Epidemiology of non-alcoholic fatty liver disease in Asia
Wong, S., & Chan, W. (2020) · Indian Journal of Gastroenterology · doi:10.1007/s12664-020-01018-x · Cited by 80
The prevalence and associated factors of metabolic syndrome in Chinese aging population
Ge, H., Yang, Z., Li, X., Liu, D., Li, Y., Pan, Y., Luo, D., & Wu, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-77184-x · Cited by 79
Ng, J., & Wu, J. J. (2012) · Hepatitis Monthly · doi:10.5812/hepatmon.7635 · Cited by 78
Osaki, Y., & Nishikawa, H. (2014) · Hepatology Research · doi:10.1111/hepr.12378 · Cited by 76
Metabolic syndrome and liver-related events: a systematic review and meta-analysis
Ren, H., Wang, J., Gao, Y., Yang, F., & Huang, W. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0366-3 · Cited by 76
Li, Y.-R., Wang, J., Tang, Y.-H., Han, X., Liu, B., Hu, H., Li, X.-L., Yang, K., Yuan, J., Miao, X., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174291 · Cited by 71
Jin, F., Xiong, W.-J., Jing, J.-C., Feng, Z., Qu, L., & Shen, X. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0970-0 · Cited by 68
Kim, B. H., Lim, Y., Kim, E., Kong, H., Won, Y., Han, S., Park, S., & Hwang, J. S. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13848 · Cited by 61
Wasitthankasem, R., Posuwan, N., Vichaiwattana, P., Theamboonlers, A., Klinfueng, S., Vuthitanachot, V., Thanetkongtong, N., Saelao, S., Foonoi, M., Fakthongyoo, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149362 · Cited by 59
Cancer survival in patients from a hospital-based cancer registry, China
Chen, J., Chen, H., Zhu, J. S., Yang, Y., Zhang, Y., Huang, P., Chen, Y., Zhu, C., Yang, L.-P., Shen, K., et al. (2018) · Journal of Cancer · doi:10.7150/jca.23039 · Cited by 57
Hepatocellular carcinoma statistics in South Korea
Chon, Y. E., Jeong, S. W., & Jun, D. W. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0171 · Cited by 54
Kwak, H. A., Park, J., Nam, B., Yu, A., Woo, S. M., Kim, T. H., Kim, S. H., Koh, Y. H., Kim, H. B., Park, S., et al. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12470 · Cited by 53
A Two-Dose Hepatitis B Vaccine for Adults (Heplisav-B)
(2018) · JAMA · doi:10.1001/jama.2018.1097 · Cited by 51
Hepatitis C virus infection in China: an emerging public health issue
Qin, Q., Smith, M. K., Wang, L., Su, Y., Wang, L., Guo, W. P., Wang, L., Cui, Y., & Wang, N. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12295 · Cited by 50
Circulating Tumor DNA and Hepatocellular Carcinoma
Yang, J. D., Liu, M., & Kisiel, J. B. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688503 · Cited by 46
Laszkowska, M., Rodriguez, S., Kim, J., & Hur, C. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001166 · Cited by 45
An, L., Zheng, R., Zhang, S., Chen, R., Wang, S., Sun, K., Lu, L., Zhang, X., Zhao, H., Zeng, H., et al. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-75 · Cited by 45
Self-citationGao, Y., Yang, J., Sun, F., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz040 · Cited by 43
Towards the elimination of viral hepatitis in Thailand by the year 2030
Posuwan, N., Wanlapakorn, N., Sintusek, P., Wasitthankasem, R., Poovorawan, K., Vongpunsawad, S., & Poovorawan, Y. (2020) · Journal of Virus Eradication · doi:10.1016/j.jve.2020.100003 · Cited by 43
Yao, S., Johnson, C. B., Hu, Q., Yan, L., Liu, B., Ambrosone, C. B., Wang, J., & Liu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.9636 · Cited by 41
Why is it so difficult to develop a hepatitis C virus preventive vaccine?
Zingaretti, C., Francesco, R. D., & Abrignani, S. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12493 · Cited by 37
Mutational Processes in Hepatocellular Carcinoma: The Story of Aristolochic Acid
Nault, J., & Letouzé, É. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1685516 · Cited by 37
Patel, N. S., Hooker, J. C., Gonzalez, M. P., Bhatt, A., Nguyen, P., Ramirez, K., Richards, L., Rizo, E., Hernandez, C., Kisseleva, T., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.09.150 · Cited by 35
Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma
Ho, S., Liu, P., Hsu, C., Hsia, C., Huang, Y., Lei, H.-J., Su, C., Lee, R., Hou, M., & Huo, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-61028-9 · Cited by 34
Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study
Sinn, D. H., Kang, D., Güallar, E., Chang, Y., Ryu, S., Zhao, D., Hong, Y. S., Cho, J., & Gwak, G. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000966 · Cited by 27
Goh, G. B., Li, J. W., Chang, J. P.-E., Chow, K., & Tan, C. (2017) · Hepatology Communications · doi:10.1002/hep4.1059 · Cited by 25
Lee, Y., Seo, Y. S., Kim, J. H., Lee, J., Kim, H. R., Yoo, Y. J., Kim, T. S., Kang, S. H., Suh, S. J., Joo, M. K., et al. (2017) · Gut and Liver · doi:10.5009/gnl17040 · Cited by 20
Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan
Lin, Y., Lin, C., Sedghi, T., Hsu, S. H., Gross, C. P., Wang, J., & Wang, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240542 · Cited by 19
Mansoor, H., Masood, M. A., Siddique, K., Badar, F., & Yusuf, M. A. (2019) · Biomedical Research and Therapy · doi:10.15419/bmrat.v6i11.577 · Cited by 4
Cited by
Singal, A. G., Kanwal, F., & Llovet, J. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00825-3 · Cited by 951
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Metadata
- Authors
- Zhang, C., Cheng, Y., Zhang, S., Fan, J., & Gao, Q.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2022-04-03
- Volume
- 42
- Issue
- 9
- Pages
- 2029-2041
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W4220778376
- Cited by
- 335
- References
- 101
- FWCI
- 38.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.